ARQT Arcutis Biotherapeutics, Inc. - Common stock
$27,03
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$15–$32
72% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$37
+36% upside
P/E (TTM)
-207.9
ROE
-9.8%
Nettogewinnmarge
-4.3%
ARQT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$27.03
Marktkapitalisierung
$3.33B
P/E (TTM)
-207.9
EPS (TTM)
$-0.13
Umsatz (TTM)
$376M
Dividendenrendite
—
ROE
-9.8%
Verschuldungsgrad
0.6
52W-Spanne
$15 – $32
ARQT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$376M
2020-12-31
→
2025-12-31
EPS
$-0.13
2019-12-31
→
2025-12-31
Freier Cashflow
$-6M
2020-12-31
→
2025-12-31
Margen
-4.3%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ARQT
Peer-Median
P/E (TTM)
-207.9
—
P/S (TTM) (K/V (TTM))
8.9
18.3
P/B (K/B)
17.6
3.3
EV / EBITDA
-278.1
—
Price / FCF (Kurs / FCF)
-528.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ARQT
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-3.2%
—
Net Profit Margin (Nettogewinnmarge)
-4.3%
-180.4%
ROA
-4.1%
-36.2%
ROE
-9.8%
-43.7%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ARQT
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.6
—
Current Ratio (Liquiditätsgrad)
3.2
9.7
Quick Ratio
1.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ARQT
Peer-Median
Revenue YoY (Umsatz YoY)
91.3%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
367.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ARQT
Peer-Median
ARQT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 4 28,6%
- Kauf 8 57,1%
- Halten 2 14,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-13
Median
$37.00
← Unter allen Zielen
$27.03
Tief
$34.00
Hoch
$40.00
Median-Ziel
$37.00
+36,9%
Mittelwert-Ziel
$36.88
+36,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.05%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.11 | $0.04 | 0.07% |
| 31. März 2026 | $-0.09 | $-0.08 | -0.01% |
| 31. Dezember 2025 | $0.13 | $0.12 | 0.01% |
| 30. September 2025 | $0.06 | $-0.10 | 0.16% |
| 30. Juni 2025 | $-0.13 | $-0.16 | 0.03% |
| 31. März 2025 | $-0.20 | $-0.21 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Cashflow 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | -253,422,862 | 127,623,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | -258,684,862 | 132,885,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $352M | · | $291M | $223M | $191M | · | $163M | $124M | $96M | · | $47M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $-5M | $-45M | · | $-75M | $-135M | $-154M | · | $-174M | $-203M | $-231M | · | $-304M | $-326M | $-320M | · | $-296M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | -524.4 | -65.4 | · | -31.4 | -13.0 | -12.3 | · | -5.2 | -3.5 | -2.8 | · | -1.0 | -1.7 | -1.9 | · | -3.4 | |
| P/S | 7.9 | 8.4 | · | 7.8 | 7.5 | 9.8 | · | 6.7 | 8.8 | · | · | 7.0 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | 1315.8 | · | · | · | -60.1 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 205.0 | -332.3 | · | 273.1 | -117.4 | -78.2 | · | -29.6 | -24.0 | · | · | -11.4 | · | · | · | -12.2 | |
| EV / FCF | · | 1349.1 | · | · | · | -61.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 8.1 | 8.6 | · | 8.0 | 7.7 | 10.0 | · | 7.1 | 9.7 | · | · | 9.0 | · | · | · | 1764.4 | |
| Earnings Yield | -0.19% | -1.5% | · | -3.2% | -7.7% | -8.1% | · | -19.4% | -28.3% | -35.5% | · | -95.9% | -59.5% | -52.5% | · | -29.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $376M | $197M | $60M | $4M | $0 |
| Betriebsgewinnmarge % | -3.2% | -65.3% | -404.5% | — | — |
| Nettoergebnis | $-16M | $-140M | $-262M | $-311M | $-206M |
| Verwässerte EPS | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.7 | 2.3 | — | — |
| Liquiditätsgrad | 3.2 | 4.1 | 7.1 | — | — |
| Quick Ratio | 1.5 | 1.8 | 2.4 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-6M | $-112M | $-247M | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 292 Einreicher · $2.6B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 47 (+10 vs. Vorquartal) | 33 (-9 vs. Vorquartal) | 90 (-8 vs. Vorquartal) | 96 (+4 vs. Vorquartal) | +5.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326.098.140 | 12.437.000 | 12,35% | Aktien |
| Frazier Life Sciences Management, L.P. | $258.909.678 | 9.874.511 | 9,80% | Aktien |
| Rubric Capital Management LP | $216.880.749 | 8.271.577 | 8,21% | Aktien |
| Polar Capital Holdings Plc | $173.234.098 | 6.606.945 | 6,56% | Aktien |
| STATE STREET CORP | $152.674.865 | 5.822.840 | 5,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $130.805.182 | 4.988.756 | 4,95% | Aktien |
| JENNISON ASSOCIATES LLC | $86.505.943 | 3.299.235 | 3,28% | Aktien |
| D. E. Shaw & Co., Inc. | $81.220.383 | 3.097.650 | 3,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $67.179.379 | 2.561.595 | 2,54% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63.688.511 | 2.429.005 | 2,41% | Aktien |
| ORBIMED ADVISORS LLC | $53.541.240 | 2.042.000 | 2,03% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $50.474.363 | 1.925.031 | 1,91% | Aktien |
| JANUS HENDERSON GROUP PLC | $42.621.972 | 1.809.466 | 1,61% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $35.998.513 | 1.372.941 | 1,36% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $34.432.392 | 1.313.211 | 1,30% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $33.175.720 | 1.265.283 | 1,26% | Aktien |
| BANK OF AMERICA CORP /DE/ | $33.121.130 | 1.263.201 | 1,25% | Aktien |
| BAMCO INC /NY/ | $32.856.806 | 1.253.120 | 1,24% | Aktien |
| CITADEL ADVISORS LLC | $29.766.543 | 1.135.261 | 1,13% | Aktien |
| Aberdeen Group plc | $28.635.465 | 1.092.123 | 1,08% | Aktien |
| Jones Hill Capital LP | $28.571.960 | 1.089.701 | 1,08% | Aktien |
| GOLDMAN SACHS GROUP INC | $28.558.011 | 1.089.169 | 1,08% | Aktien |
| Perpetual Ltd | $27.642.802 | 1.054.264 | 1,05% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27.555.489 | 1.050.934 | 1,04% | Aktien |
| Ensign Peak Advisors, Inc | $25.552.281 | 974.534 | 0,97% | Aktien |
| Candriam S.C.A. | $24.880.817 | 949.839 | 0,94% | Aktien |
| Driehaus Capital Management LLC | $23.032.330 | 878.426 | 0,87% | Aktien |
| VANGUARD GROUP INC | $22.159.001 | 763.051 | 0,84% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $21.372.918 | 815.138 | 0,81% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21.284.137 | 811.752 | 0,81% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $17.406.855 | 663.877 | 0,66% | Aktien |
| FISHMAN JAY A LTD/MI | $15.601.031 | 595.005 | 0,59% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $14.789.968 | 564.072 | 0,56% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $14.349.629 | 547.278 | 0,54% | Aktien |
| Squarepoint Ops LLC | $14.099.726 | 537.747 | 0,53% | Aktien |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13.110.000 | 500.000 | 0,50% | Aktien |
| Nearwater Capital Markets, Ltd | $12.761.274 | 486.700 | 0,48% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.218.520 | 466.000 | 0,46% | Aktien |
| Privium Fund Management B.V. | $10.471.403 | 399.367 | 0,40% | Aktien |
| NORGES BANK | $10.286.106 | 392.300 | 0,39% | Aktien |
| Patient Square Capital LP | $9.701.400 | 370.000 | 0,37% | Aktien |
| Point72 Asset Management, L.P. | $9.503.413 | 362.449 | 0,36% | Aktien |
| Qube Research & Technologies Ltd | $9.482.778 | 361.662 | 0,36% | Aktien |
| Longaeva Partners L.P. | $9.040.551 | 344.796 | 0,34% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.741.748 | 333.400 | 0,33% | Kaufoption |
| FMR LLC | $8.001.453 | 305.166 | 0,30% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7.641.740 | 291.447 | 0,29% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $7.467.168 | 284.789 | 0,28% | Aktien |
| FIRST TRUST ADVISORS LP | $7.448.184 | 284.065 | 0,28% | Aktien |
| AMERIPRISE FINANCIAL INC | $7.133.676 | 272.070 | 0,27% | Aktien |
| Walleye Capital LLC | $6.818.065 | 260.033 | 0,26% | Aktien |
| Balyasny Asset Management L.P. | $6.374.580 | 243.119 | 0,24% | Aktien |
| PFM Health Sciences, LP | $6.347.049 | 242.069 | 0,24% | Aktien |
| MYDA Advisors LLC | $6.292.800 | 240.000 | 0,24% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $6.054.329 | 230.905 | 0,23% | Aktien |
| Swiss National Bank | $5.873.280 | 224.000 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.763.549 | 219.815 | 0,22% | Aktien |
| Pictet Asset Management Holding SA | $5.350.188 | 200.275 | 0,20% | Aktien |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $5.235.688 | 199.683 | 0,20% | Aktien |
| Woodline Partners LP | $5.113.765 | 195.033 | 0,19% | Aktien |
| BlackRock, Inc. | $4.724.084 | 180.171 | 0,18% | Aktien |
| Cormorant Asset Management, LP | $4.588.500 | 175.000 | 0,17% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $4.586.166 | 174.911 | 0,17% | Aktien |
| TWO SIGMA ADVISERS, LP | $4.533.144 | 156.100 | 0,17% | Aktien |
| RHUMBLINE ADVISERS | $4.471.596 | 170.542 | 0,17% | Aktien |
| Holocene Advisors, LP | $4.293.053 | 163.732 | 0,16% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4.127.788 | 157.429 | 0,16% | Aktien |
| PDT Partners, LLC | $4.066.067 | 155.075 | 0,15% | Aktien |
| CITIGROUP INC | $3.796.394 | 144.790 | 0,14% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3.616.499 | 137.929 | 0,14% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.605.250 | 137.500 | 0,14% | Aktien |
| CASTLEARK MANAGEMENT LLC | $3.603.152 | 137.420 | 0,14% | Aktien |
| Eversept Partners, LP | $3.549.008 | 135.355 | 0,13% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $3.491.088 | 133.146 | 0,13% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $3.458.785 | 131.914 | 0,13% | Aktien |
| MORGAN STANLEY | $3.424.175 | 130.594 | 0,13% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $3.213.419 | 136.393 | 0,12% | Aktien |
| JANE STREET GROUP, LLC | $3.088.716 | 117.800 | 0,12% | Kaufoption |
| 1492 Capital Management LLC | $3.047.052 | 116.211 | 0,12% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.023.149 | 128.317 | 0,11% | Aktien |
| Tejara Capital Ltd | $2.965.062 | 113.084 | 0,11% | Aktien |
| LPL Financial LLC | $2.914.353 | 111.150 | 0,11% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.776.671 | 103.762 | 0,11% | Aktien |
| STEMPOINT CAPITAL LP | $2.594.338 | 98.945 | 0,10% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.496.000 | 95.197 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $2.480.412 | 94.600 | 0,09% | Kaufoption |
| Aquatic Capital Management LLC | $2.258.329 | 86.130 | 0,09% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.255.628 | 86.027 | 0,09% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $2.135.488 | 81.445 | 0,08% | Aktien |
| WESBANCO BANK INC | $2.126.442 | 81.100 | 0,08% | Aktien |
| Rafferty Asset Management, LLC | $2.117.973 | 80.777 | 0,08% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $1.981.498 | 75.572 | 0,08% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $1.980.685 | 75.541 | 0,07% | Aktien |
| Erste Asset Management GmbH | $1.956.156 | 73.100 | 0,07% | Aktien |
| FEDERATED HERMES, INC. | $1.952.315 | 74.459 | 0,07% | Aktien |
| Jain Global LLC | $1.917.757 | 73.141 | 0,07% | Aktien |
| Vontobel Holding Ltd. | $1.789.305 | 68.242 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $1.747.012 | 66.629 | 0,07% | Aktien |
| Focus Partners Wealth | $1.651.363 | 62.981 | 0,06% | Aktien |
| CenterBook Partners LP | $1.597.925 | 60.943 | 0,06% | Aktien |
Unternehmensinsider 18 Insider · 2 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott L Burrows | Chief Financial Officer | 27. Dezember 2021 S | 22.679 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 4. Februar 2020 C | 270.279 | 0 | 0 | $0 |
| Howard G. Welgus | Direktor | 15. Juli 2026 M | 37.109 | 0 | 3 | $-243.567 |
| Christopher Peetz | Direktor | 15. Juli 2026 A | 4.315 | 0 | 0 | $0 |
| Sue-Jean Lin | Direktor | 15. Juni 2026 S | 27.567 | 0 | 1 | $-120.583 |
| Neha Krishnamohan | Direktor | 5. Juni 2026 A | 27.901 | 0 | 0 | $0 |
| Terrie Curran | Direktor | 5. Juni 2026 A | 23.526 | 0 | 0 | $0 |
| Amit Munshi | Direktor | 5. Juni 2026 A | 9.799 | 0 | 0 | $0 |
| Halley E Gilbert | Direktor | 5. Juni 2026 A | 27.901 | 0 | 0 | $0 |
| Keith R Leonard | Direktor | 5. Juni 2026 A | 27.901 | 0 | 0 | $0 |
| Patrick J. Heron | Direktor | 5. Juni 2026 A | 32.213 | 0 | 0 | $0 |
| Jonathan Silverstein | Direktor | 2. Oktober 2020 P | 902.286 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Direktor | 4. Februar 2020 C | 49.981 | 0 | 0 | $0 |
| Joseph L Turner | Direktor | 30. Januar 2020 A | — | 0 | 0 | $0 |
| Patrick Burnett | — | 12. August 2026 M | 119.289 | 0 | 3 | $-419.797 |
| Todd Franklin Watanabe | — | 3. August 2026 S | 717.203 | 0 | 1 | $-114.275 |
| Masaru Matsuda | — | 3. August 2026 S | 126.171 | 0 | 1 | $-32.128 |
| Ricky Sun | — | 9. Juni 2021 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 Einreichungen | 20. August 2025 | 7,50% | Änderung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 Einreichungen | 26. August 2022 | — | Erste Einreichung | — | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 Einreichungen | 8. August 2022 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,38% | 134.950 SH | 8. August 2026 | Täglich |
| BBP · ETFis Series Trust I | 1,28% | 32.610 NS | 30. April 2026 | N-PORT |
| GURU · Global X Funds | 0,95% | 23.918 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,88% | 196.991 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,54% | 70.043 NS | 31. Mai 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 64.844 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,32% | 145.888 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,23% | 812.141 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,22% | 6.809 SH | 8. August 2026 | Täglich |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,20% | 9.018 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,19% | 1.035.865 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122.691 SH | 8. August 2026 | Täglich |
| OASC · Unified Series Trust | 0,17% | 6.744 NS | 31. Mai 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,17% | 88.401 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,16% | 74.441 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 4.587 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 41.766 NS | 30. April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,11% | 3.711 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 2.886.529 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658.480 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,09% | 33.974 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,08% | 85.491 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,08% | 47.709 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55.080 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 13.604 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 5.179 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 534.058 NS | 31. Mai 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.598 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 51.951 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,04% | 4.781 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 50.560 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 335.913 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,03% | 4.051 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.307.970 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,03% | 4.104 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 6.296 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4.427 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 103 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 33.557 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.941 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 31.312 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 3.054 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 64.126 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.565.928 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.521 SH | 8. August 2026 | Täglich |